217 related articles for article (PubMed ID: 33340266)
1. Gabapentin reduces painful bladder hypersensitivity in rats with lipopolysaccharide-induced chronic cystitis.
Yoshizumi M; Watanabe C; Mizoguchi H
Pharmacol Res Perspect; 2021 Feb; 9(1):e00697. PubMed ID: 33340266
[TBL] [Abstract][Full Text] [Related]
2. Effect of Intravesical Liposome-Based Nerve Growth Factor Antisense Therapy on Bladder Overactivity and Nociception in a Rat Model of Cystitis Induced by Hydrogen Peroxide.
Majima T; Tyagi P; Dogishi K; Kashyap M; Funahashi Y; Gotoh M; Chancellor MB; Yoshimura N
Hum Gene Ther; 2017 Jul; 28(7):598-609. PubMed ID: 28446032
[TBL] [Abstract][Full Text] [Related]
3. TRPV4 activation prevents lipopolysaccharide-induced painful bladder hypersensitivity in rats by regulating immune pathways.
Yoshizumi M; Tazawa N; Watanabe C; Mizoguchi H
Front Immunol; 2022; 13():1080302. PubMed ID: 36618411
[TBL] [Abstract][Full Text] [Related]
4. Suppression of adenosine A
Yang Y; Zhang H; Lu Q; Liu X; Fan Y; Zhu J; Sun B; Zhao J; Dong X; Li L
Biochem Pharmacol; 2021 Jan; 183():114340. PubMed ID: 33189675
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic effect of modulating the NLRP3-regulated transforming growth factor-β signaling pathway on interstitial cystitis/bladder pain syndrome.
Shih HJ; Chang CY; Lai CH; Huang CJ
Biomed Pharmacother; 2021 Jun; 138():111522. PubMed ID: 34311526
[TBL] [Abstract][Full Text] [Related]
6. Effects of low-intensity extracorporeal shock wave therapy on lipopolysaccharide cystitis in a rat model of interstitial cystitis/bladder pain syndrome.
Kusakabe N; Kamijo TC; Wada N; Chiba H; Shinohara N; Miyazato M
Int Urol Nephrol; 2024 Jan; 56(1):77-86. PubMed ID: 37668867
[TBL] [Abstract][Full Text] [Related]
7. Mast cell activation and response to tolterodine in the rat urinary bladder in a chronic model of intravesical protamine sulfate and bacterial endotoxin-induced cystitis.
Choi BH; Jin LH; Kim KH; Han JY; Kang JH; Yoon SM; Park CS; Lee T
Mol Med Rep; 2014 Aug; 10(2):670-6. PubMed ID: 24859757
[TBL] [Abstract][Full Text] [Related]
8. Investigations of urethral sphincter activity in mice with bladder hyperalgesia before and after drug administration of gabapentin.
Yeh JC; Do R; Choi H; Lin CT; Chen JJ; Zi X; Chang HH; Ghoniem G
Int Urol Nephrol; 2019 Jan; 51(1):53-59. PubMed ID: 30387068
[TBL] [Abstract][Full Text] [Related]
9. Cross-organ sensitization between the prostate and bladder in an experimental rat model of lipopolysaccharide (LPS)-induced chronic pelvic pain syndrome.
Aydogdu O; Gocun PU; Aronsson P; Carlsson T; Winder M
BMC Urol; 2021 Aug; 21(1):113. PubMed ID: 34419040
[TBL] [Abstract][Full Text] [Related]
10. Effect of eviprostat on bladder overactivity in an experimental cystitis rat model.
Kobayashi M; Nomura M; Nishii H; Matsumoto S; Fujimoto N; Matsumoto T
Int J Urol; 2008 Apr; 15(4):356-60. PubMed ID: 18380828
[TBL] [Abstract][Full Text] [Related]
11. N-acetylcysteine prevents bladder tissue fibrosis in a lipopolysaccharide-induced cystitis rat model.
Ryu CM; Shin JH; Yu HY; Ju H; Kim S; Lim J; Heo J; Lee S; Shin DM; Choo MS
Sci Rep; 2019 May; 9(1):8134. PubMed ID: 31148586
[TBL] [Abstract][Full Text] [Related]
12. [Urodynamic and histological evaluation of cyclophosphamide-induced bladder pain syndrome in SD rats].
Zhu L; Zhang WY; Xu KX
Beijing Da Xue Xue Bao Yi Xue Ban; 2022 Aug; 54(4):735-740. PubMed ID: 35950400
[TBL] [Abstract][Full Text] [Related]
13. Bladder wall injection of mesenchymal stem cells ameliorates bladder inflammation, overactivity, and nociception in a chemically induced interstitial cystitis-like rat model.
Furuta A; Yamamoto T; Igarashi T; Suzuki Y; Egawa S; Yoshimura N
Int Urogynecol J; 2018 Nov; 29(11):1615-1622. PubMed ID: 29508044
[TBL] [Abstract][Full Text] [Related]
14. Effect of silymarin on bladder overactivity in cyclophosphamide-induced cystitis rat model.
Eser N; Göçmen C; Erdoğan S; Büyüknacar HS; Kumcu EK; Açıkalın A; Önder S
Phytomedicine; 2012 Jun; 19(8-9):840-5. PubMed ID: 22647456
[TBL] [Abstract][Full Text] [Related]
15. Intravesical hyaluronidase causes chronic cystitis in a rat model: a potential model of bladder pain syndrome/interstitial cystitis.
Lv YS; Yao YS; Rong L; Lin ME; Deng BH; Xie Y; Huang H; Lin TX; Xu KW; Huang J
Int J Urol; 2014 Jun; 21(6):601-7. PubMed ID: 24286489
[TBL] [Abstract][Full Text] [Related]
16. Anti-inflammatory iron chelator, DIBI, reduces leukocyte-endothelial adhesion and clinical symptoms of LPS-induced interstitial cystitis in mice.
Hagn G; Holbein B; Zhou J; Lehmann C
Clin Hemorheol Microcirc; 2021; 79(3):395-406. PubMed ID: 34250933
[TBL] [Abstract][Full Text] [Related]
17. Ba-Wei-Die-Huang-Wan (Hachimi-jio-gan) can ameliorate ketamine-induced cystitis by modulating neuroreceptors, inflammatory mediators, and fibrogenesis in a rat model.
Lee WC; Tain YL; Chuang YC; Tsai CN; Yu CC; Su CH
Neurourol Urodyn; 2019 Nov; 38(8):2159-2169. PubMed ID: 31541501
[TBL] [Abstract][Full Text] [Related]
18. Sequestration of brain derived nerve factor by intravenous delivery of TrkB-Ig2 reduces bladder overactivity and noxious input in animals with chronic cystitis.
Pinto R; Frias B; Allen S; Dawbarn D; McMahon SB; Cruz F; Cruz CD
Neuroscience; 2010 Mar; 166(3):907-16. PubMed ID: 20079809
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical evidence suggests repeated intravesical application of botulinum toxin A injections may improve treatment efficacy of interstitial cystitis/bladder pain syndrome.
Shie JH; Liu HT; Wang YS; Kuo HC
BJU Int; 2013 Apr; 111(4):638-46. PubMed ID: 22943596
[TBL] [Abstract][Full Text] [Related]
20. Adverse Events of Intravesical OnabotulinumtoxinA Injection between Patients with Overactive Bladder and Interstitial Cystitis--Different Mechanisms of Action of Botox on Bladder Dysfunction?
Kuo YC; Kuo HC
Toxins (Basel); 2016 Mar; 8(3):. PubMed ID: 26999201
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
